Search

Your search keyword '"K, Tanabe"' showing total 1,708 results

Search Constraints

Start Over You searched for: Author "K, Tanabe" Remove constraint Author: "K, Tanabe" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
1,708 results on '"K, Tanabe"'

Search Results

1. Blockage of Akt activation suppresses cadmium-induced renal tubular cellular damages through aggrephagy in HK-2 cells

2. An angiotensin system inhibitor (losartan) potentiates antitumor efficacy of cisplatin in a murine model of non–small cell lung cancerCentral MessagePerspective

3. Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention Strategy

4. Inter-nesting, migration, and foraging behaviors of green turtles (Chelonia mydas) in the central-southern Red Sea

5. Low diversity and abundance of predatory fishes in a peripheral coral reef ecosystem

6. Molecular magnetic resonance imaging of liver inflammation using an oxidatively activated probe

7. Case report: tracking data from foraging hawksbill turtles in the northern Red Sea

8. Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in LiverSummary

9. A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery

10. Evaluation of multi-bit domain wall motion by low current density to obtain ultrafast data rate in a compensated ferrimagnetic wire

11. An assessment of heavy metals in green sea turtle (Chelonia mydas) hatchlings from Saudi Arabia’s largest rookery, Ras Baridi

12. Newly described nesting sites of the green sea turtle (Chelonia mydas) and the hawksbill sea turtle (Eretmochelys imbricata) in the central Red Sea

13. Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation

14. Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram

15. Ammonoid soft tissue remains revealed by computed tomography

16. Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis

17. A multi-method characterization of Elasmobranch & Cheloniidae communities of the north-eastern Red Sea and Gulf of Aqaba.

18. A Preliminary Report of Plastic Ingestion by Hawksbill and Green Turtles in the Saudi Arabian Red Sea

19. Satellite Tracking Reveals Nesting Patterns, Site Fidelity, and Potential Impacts of Warming on Major Green Turtle Rookeries in the Red Sea

20. A study of volatility by composition, heating, and dilution measurements of secondary organic aerosol from 1,3,5-trimethylbenzene

22. Potential feminization of Red Sea turtle hatchlings as indicated by in situ sand temperature profiles

26. Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP‐305, a novel farnesoid X receptor agonist

27. Studying volatility from composition, dilution, and heating measurements of secondary organic aerosols formed during α-pinene ozonolysis

28. Proteomic profiling of extracellular matrix components from patient metastases identifies consistently elevated proteins for developing nanobodies that target primary tumors and metastases

29. Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI

30. Tailored chemical reactivity probes for systemic imaging of aldehydes in fibroproliferative diseases

31. Data from TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

32. Table S1 from TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

33. Figure S1 and S2 from TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

35. SUPPLEMENTARY DATA from PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma

37. Supplementary Table 3 from Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic Cholangiocarcinoma

38. Supplementary Legends, Table from Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI

39. Figure from Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI

40. Supplementary Table 2 from Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic Cholangiocarcinoma

41. Data from PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma

42. Data from Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug Combinations

43. Data from Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI

44. Supplementary Table 1 from Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug Combinations

45. Supplementary Table 1 from Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic Cholangiocarcinoma

46. Data Supplement from Molecular Imaging with Bioluminescence and PET Reveals Viral Oncolysis Kinetics and Tumor Viability

47. Evaluation of the Intrinsic and Perceived Quality of Sangiovese Wines from California and Italy

48. The Use of Macro, Micro, and Trace Elemental Profiles to Differentiate Commercial Single Vineyard Pinot noir Wines at a Sub-Regional Level

49. Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy

50. Rivaroxaban Monotherapy in Patients With Atrial Fibrillation After Coronary Stenting

Catalog

Books, media, physical & digital resources